{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:04:03Z","timestamp":1780121043330,"version":"3.54.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["124020500028-4"],"award-info":[{"award-number":["124020500028-4"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00203-026-04820-x","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:48:11Z","timestamp":1773758891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibacterial activity of lantibiotics, alone and in combination with colistin, against Gram-negative bacteria"],"prefix":"10.1007","volume":"208","author":[{"given":"Aleksandr","family":"Lobanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Eroshenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Esaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Polyudova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"4820_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-022-03471-6","volume":"39","author":"A Abolmaaty","year":"2022","unstructured":"Abolmaaty A, Abdelkader RMM, Amin DH (2022) Synergistic inhibition of Pseudomonas fluorescens growth and proteases activities via sodium chlorite-based oxyhalogen. World J Microbiol Biotechnol 39:33. https:\/\/doi.org\/10.1007\/s11274-022-03471-6","journal-title":"World J Microbiol Biotechnol"},{"issue":"3","key":"4820_CR2","doi-asserted-by":"publisher","DOI":"10.15171\/ijb.1867","volume":"16","author":"A Avand","year":"2018","unstructured":"Avand A, Akbari V, Shafizadegan S (2018) In vitro cytotoxic activity of a Lactococcus lactis antimicrobial peptide against breast cancer cells. Iran J Biotechnol 16(3):e1867. https:\/\/doi.org\/10.15171\/ijb.1867","journal-title":"Iran J Biotechnol"},{"key":"4820_CR3","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2015) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard, 10th edn. CLSI document M07-A10. Wayne, PA, USA"},{"key":"4820_CR4","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2021) Performance standards for antimicrobial susceptibility testing, 31st edn. CLSI supplement M100. Clinical and Laboratory Standards Institute"},{"key":"4820_CR5","doi-asserted-by":"publisher","DOI":"10.3791\/57713","author":"M Cokol-Cakmak","year":"2018","unstructured":"Cokol-Cakmak M, Bakan F, Cetiner S, Cokol M (2018) Diagonal method to measure synergy among any number of drugs. J vis Exp (JoVE). https:\/\/doi.org\/10.3791\/57713","journal-title":"J vis Exp (JoVE)"},{"key":"4820_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1134\/S0026261715030030","volume":"84","author":"VA Demakov","year":"2015","unstructured":"Demakov VA, Vasiliev DM, Maksimova YG, Pavlova YA, Ovechkina GV, Maksimov AY (2015) Bacteria of activated sludge from biological treatment plants that transform cyanopyridines and amides of pyridinecarboxylic acids. Microbiology 84:433\u2013441. https:\/\/doi.org\/10.1134\/S0026261715030030","journal-title":"Microbiology"},{"issue":"2","key":"4820_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ja.2013.111","volume":"67","author":"ZZ Deris","year":"2014","unstructured":"Deris ZZ, Akter J, Sivanesan S, Roberts KD, Thompson PE, Nation RL, Li J, Velkov T (2014) A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot 67(2):147\u2013151. https:\/\/doi.org\/10.1038\/ja.2013.111","journal-title":"J Antibiot"},{"key":"4820_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijantimicag.2023.106899","volume":"304","author":"J Dischinger","year":"2014","unstructured":"Dischinger J, Chipalu SB, Bierbaum G (2014) Lantibiotics: promising candidates for future applications in health care. Int J Med Microbiol 304:51\u201362. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106899","journal-title":"Int J Med Microbiol"},{"key":"4820_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-13-212","volume":"13","author":"LA Draper","year":"2013","unstructured":"Draper LA, Cotter PD, Hill C, Ross RP (2013) The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram-negative bacteria. BMC Microbiol 13:212. https:\/\/doi.org\/10.1186\/1471-2180-13-212","journal-title":"BMC Microbiol"},{"key":"4820_CR10","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2017.5063","volume":"15","author":"M Younes","year":"2017","unstructured":"EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, Gott D et al (2017) Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use. EFSA J 15:e05063. https:\/\/doi.org\/10.2903\/j.efsa.2017.5063","journal-title":"EFSA J"},{"key":"4820_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab026","volume":"8","author":"K Eljaaly","year":"2021","unstructured":"Eljaaly K, Bidell MR, Gandhi RG, Alshehri S, Enani MA, Al-Jedai A, Lee TC (2021) Colistin nephrotoxicity: meta-analysis of randomized controlled trials. Open Forum Infect Dis 8:ofab026. https:\/\/doi.org\/10.1093\/ofid\/ofab026","journal-title":"Open Forum Infect Dis"},{"key":"4820_CR12","doi-asserted-by":"publisher","unstructured":"European Food Safety Authority, European Centre for Disease Prevention and Control (2023) The European Union One Health 2022 Zoonoses Report. EFSA J 21:e8442. https:\/\/doi.org\/10.2903\/j.efsa.2023.8442","DOI":"10.2903\/j.efsa.2023.8442"},{"key":"4820_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01713","volume":"7","author":"D Field","year":"2016","unstructured":"Field D, Seisling N, Cotter PD, Ross RP, Hill C (2016) Synergistic nisin-polymyxin combinations for the control of Pseudomonas biofilm formation. Front Microbiol 7:1713. https:\/\/doi.org\/10.3389\/fmicb.2016.01713","journal-title":"Front Microbiol"},{"key":"4820_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-026-06536-w","author":"SV Gein","year":"2026","unstructured":"Gein SV, Polyudova TV, Ibatullin MV (2026) Immunomodulatory activity of lantibiotics isolated from growth media of coagulase-negative staphylococci in vitro. Bull Exp Biol Med. https:\/\/doi.org\/10.1007\/s10517-026-06536-w","journal-title":"Bull Exp Biol Med"},{"key":"4820_CR15","doi-asserted-by":"publisher","DOI":"10.5812\/archcid-148571","volume":"19","author":"H Ghahramanpour","year":"2024","unstructured":"Ghahramanpour H, Hashemi A, Ghalavand Z, Rad ZR, Nojookambari NY, Delfani S, Hajikhani B (2024) Exploring the potential effects of nisin and colistin combinations against drug-resistant Klebsiella pneumoniae isolates. Arch Clin Infect Dis 19:148571. https:\/\/doi.org\/10.5812\/archcid-148571","journal-title":"Arch Clin Infect Dis"},{"key":"4820_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106899","volume":"62","author":"Y Han","year":"2023","unstructured":"Han Y, Zhang Y, Zeng W, Huang Z, Cheng H, Kong J, Cao J (2023) Synergy with farnesol rejuvenates colistin activity against colistin-resistant Gram-negative bacteria in vitro and in vivo. Int J Antimicrob Agents 62:106899. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106899","journal-title":"Int J Antimicrob Agents"},{"key":"4820_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJV (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387:176\u2013187. https:\/\/doi.org\/10.1016\/S0140-6736(15)00473-0","journal-title":"Lancet"},{"key":"4820_CR18","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1128\/JCM.36.10.2914-2917.1998","volume":"36","author":"PR Hsueh","year":"1998","unstructured":"Hsueh PR, Teng LJ, Pan HJ, Chen YC, Sun CC, Ho SW, Luh KT (1998) Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol 36:2914\u20132917. https:\/\/doi.org\/10.1128\/JCM.36.10.2914-2917.1998","journal-title":"J Clin Microbiol"},{"key":"4820_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1186\/s12879-020-05557-8","volume":"20","author":"C Huang","year":"2020","unstructured":"Huang C (2020) Extensively drug-resistant Alcaligenes faecalis infection. BMC Infect Dis 20:833. https:\/\/doi.org\/10.1186\/s12879-020-05557-8","journal-title":"BMC Infect Dis"},{"key":"4820_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13104-017-2757-8","volume":"10","author":"K Ignasiak","year":"2017","unstructured":"Ignasiak K, Maxwell A (2017) Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials. BMC Res Notes 10:428. https:\/\/doi.org\/10.1186\/s13104-017-2757-8","journal-title":"BMC Res Notes"},{"key":"4820_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/antibiotics14050515","volume":"14","author":"MJ Karau","year":"2025","unstructured":"Karau MJ, Koscianski CA, Badley AD, Bedard NA, Zinckgraf JW, Patel R (2025) In vitro activity of nisin A against staphylococci isolated from periprosthetic joint infection. Antibiotics 14:515. https:\/\/doi.org\/10.3390\/antibiotics14050515","journal-title":"Antibiotics"},{"key":"4820_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13100945","volume":"13","author":"DS Karpov","year":"2024","unstructured":"Karpov DS, Kazakova EM, Kovalev MA, Shumkov MS, Kusainova T, Tarasova IA, Osipova PJ, Poddubko SV, Mitkevich VA, Kuznetsova MV, Goncharenko AV (2024) Determinants of antibiotic resistance and virulence factors in the genome of Escherichia coli APEC 36 strain isolated from a broiler chicken with generalized colibacillosis. Antibiotics (Basel) 13:945. https:\/\/doi.org\/10.3390\/antibiotics13100945","journal-title":"Antibiotics (Basel)"},{"key":"4820_CR23","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1126\/science.1155725","volume":"320","author":"RE Ley","year":"2008","unstructured":"Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Gordon JI (2008) Evolution of mammals and their gut microbes. Science 320:1647\u20131651. https:\/\/doi.org\/10.1126\/science.1155725","journal-title":"Science"},{"issue":"1","key":"4820_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","volume":"25","author":"J Li","year":"2005","unstructured":"Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K (2005) Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25(1):11\u201325. https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.10.001","journal-title":"Int J Antimicrob Agents"},{"key":"4820_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/antibiotics9010032","volume":"9","author":"E Meade","year":"2020","unstructured":"Meade E, Slattery MA, Garvey M (2020) Bacteriocins, potent antimicrobial peptides and the fight against multidrug resistant species: resistance is futile? Antibiotics 9:32. https:\/\/doi.org\/10.3390\/antibiotics9010032","journal-title":"Antibiotics"},{"key":"4820_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance. Front Microbiol 10:539. https:\/\/doi.org\/10.3389\/fmicb.2019.00539","journal-title":"Front Microbiol"},{"key":"4820_CR27","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/AAC.02328-12","volume":"57","author":"K Naghmouchi","year":"2013","unstructured":"Naghmouchi K, Baah J, Hober D, Jouy E, Rubrecht C, San\u00e9 F, Drider D (2013) Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother 57:2719\u20132725. https:\/\/doi.org\/10.1128\/AAC.02328-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4820_CR28","unstructured":"Oliveira J, Reygaert WC (2023) Gram-negative bacteria. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK538213\/. Accessed 31 Oct 2025"},{"key":"4820_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan G, Bayram A, Zer Y, Balci I (2005) Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol 43:140\u2013143. https:\/\/doi.org\/10.1128\/JCM.43.1.140-143.2005","journal-title":"J Clin Microbiol"},{"key":"4820_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1134\/S0003683817010148","volume":"53","author":"TV Polyudova","year":"2017","unstructured":"Polyudova TV, Lemkina LM, Korobov VP, Likhatskaya GN (2017) Optimization of production conditions and 3D-structure modeling of novel antibacterial peptide of lantibiotic family. Appl Biochem Microbiol 53:40\u201346. https:\/\/doi.org\/10.1134\/S0003683817010148","journal-title":"Appl Biochem Microbiol"},{"key":"4820_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-024-03922-8","volume":"206","author":"T Polyudova","year":"2024","unstructured":"Polyudova T, Lemkina L, Eroshenko D, Esaev A (2024a) Suppression of planktonic and biofilm of Escherichia coli by the synergistic lantibiotics\u2013polymyxins combinations. Arch Microbiol 206:191. https:\/\/doi.org\/10.1007\/s00203-024-03922-8","journal-title":"Arch Microbiol"},{"key":"4820_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1134\/S0026261724606626","volume":"93","author":"TV Polyudova","year":"2024","unstructured":"Polyudova TV, Lemkina LM, Antip\u2019eva MV, Esaev AL, Korobov VP (2024b) Prevalence of production of antagonism peptide factors among coagulase-negative staphylococci. Microbiology 93:847\u2013854. https:\/\/doi.org\/10.1134\/S0026261724606626","journal-title":"Microbiology"},{"key":"4820_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-025-01322-z","author":"D RoyChowdhury","year":"2025","unstructured":"RoyChowdhury D, Manna A, Mandal S, Mukherjee P, Basu A (2025) Colistin resistance in the era of antimicrobial resistance: challenges and strategic countermeasures. Folia Microbiol. https:\/\/doi.org\/10.1007\/s12223-025-01322-z","journal-title":"Folia Microbiol"},{"key":"4820_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076844","volume":"8","author":"AP Singh","year":"2013","unstructured":"Singh AP, Prabha V, Rishi P (2013) Value addition in the efficacy of conventional antibiotics by nisin against Salmonella. PLoS ONE 8:e76844. https:\/\/doi.org\/10.1371\/journal.pone.0076844","journal-title":"PLoS ONE"},{"key":"4820_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-024-04185-z","volume":"206","author":"G Smirnova","year":"2024","unstructured":"Smirnova G, Tyulenev A, Sutormina L, Kalashnikova T, Samoilova Z, Muzyka N, Ushakov V, Oktyabrsky O (2024) Effect of H2S and cysteine homeostasis disturbance on ciprofloxacin sensitivity of Escherichia coli in cystine-free and cystine-fed minimal medium. Arch Microbiol 206:456. https:\/\/doi.org\/10.1007\/s00203-024-04185-z","journal-title":"Arch Microbiol"},{"key":"4820_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ijantimicag.2019.03.009","volume":"53","author":"VM Thomas","year":"2019","unstructured":"Thomas VM, Brown RM, Ashcraft DS, Pankey GA (2019) Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Int J Antimicrob Agents 53:663\u2013668. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.009","journal-title":"Int J Antimicrob Agents"},{"key":"4820_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24020249","volume":"24","author":"M Vaara","year":"2019","unstructured":"Vaara M (2019) Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics. Molecules 24:249. https:\/\/doi.org\/10.3390\/molecules24020249","journal-title":"Molecules"},{"key":"4820_CR38","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm900999h","volume":"53","author":"T Velkov","year":"2010","unstructured":"Velkov T, Thompson PE, Nation RL, Li J (2010) Structure\u2013activity relationships of polymyxin antibiotics. J Med Chem 53:1898\u20131916. https:\/\/doi.org\/10.1021\/jm900999h","journal-title":"J Med Chem"},{"key":"4820_CR39","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.14744\/AnatolJCardiol.2019.10576","volume":"21","author":"I Vogiatzis","year":"2019","unstructured":"Vogiatzis I, Koutsampasopoulos K (2019) Infective endocarditis caused by Alcaligenes faecalis complicated with skin lesions. Anatol J Cardiol 21:E10. https:\/\/doi.org\/10.14744\/AnatolJCardiol.2019.10576","journal-title":"Anatol J Cardiol"},{"key":"4820_CR40","unstructured":"World Health Organization (2022) The WHO AWaRe (access, watch, reserve) antibiotic book. World Health Organization"},{"key":"4820_CR41","unstructured":"World Health Organization (2024) WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance. World Health Organization"},{"key":"4820_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","volume":"13","author":"B Yadav","year":"2015","unstructured":"Yadav B, Wennerberg K, Aittokallio T, Tang J (2015) Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model. Comput Struct Biotechnol J 13:504\u2013513. https:\/\/doi.org\/10.1016\/j.csbj.2015.09.001","journal-title":"Comput Struct Biotechnol J"},{"key":"4820_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107523","author":"J Yang","year":"2025","unstructured":"Yang J, Yue H, Wang W, Lin C, Li C, Chen J, Liu YY (2025) Synergistic activity of menadione in combination with colistin against colistin-susceptible and colistin-resistant Gram-negative bacteria. Int J Antimicrob Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107523","journal-title":"Int J Antimicrob Agents"},{"key":"4820_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02378-18","volume":"63","author":"J Yin","year":"2019","unstructured":"Yin J, Wang G, Cheng D, Fu J, Qiu J, Yu Z (2019) Inactivation of polymyxin by hydrolytic mechanism. Antimicrob Agents Chemother 63:e02378-18. https:\/\/doi.org\/10.1128\/AAC.02378-18","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04820-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:48:59Z","timestamp":1780120139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04820-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4820"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04820-x","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"275"}}